Alcohol-free hand sanitizer works just as well as alcohol-based products to control COVID-19

A new study from researchers at Brigham Young University finds that alcohol-free hand sanitizer is just as effective at disinfecting surfaces from the COVID-19 virus as alcohol-based products.

The BYU scientists who conducted the study suspected that the CDC's preference for alcohol sanitizer stemmed from as-yet limited research on what really works to disinfect SARS-CoV-2. To explore other options, they treated samples of the novel coronavirus with benzalkonium chloride, which is commonly used in alcohol-free hand sanitizers, and several other quaternary ammonium compounds regularly found in disinfectants. In most of the test cases, the compounds wiped out at least 99.9% of the virus within 15 seconds.

Our results indicate that alcohol-free hand sanitizer works just as well, so we could, maybe even should, be using it to control COVID."

Benjamin Ogilvie, lead study author

Alcohol-free hand sanitizers, which are also effective against common cold and flu viruses, have a number of advantages over their alcohol-based counterparts, Ogilvie explained.

"Benzalkonium chloride can be used in much lower concentrations and does not cause the familiar 'burn' feeling you might know from using alcohol hand sanitizer. It can make life easier for people who have to sanitize hands a lot, like healthcare workers, and maybe even increase compliance with sanitizing guidelines," he said.

In the face of shortages, "having more options to disinfect hospitals and public places is critical," added Ph.D. student Antonio Solis Leal, who conducted the study's experiments.

Switching to alcohol-free hand sanitizer is logistically simple as well.

"People were already using it before 2020," said BYU professor and coauthor Brad Berges. "It just seems like during this pandemic, the non-alcohol-based hand sanitizers have been thrown by the wayside because the government was saying, 'we don't know that these work,' due to the novelty of the virus and the unique lab conditions required to run tests on it."

Since benzalkonium chloride typically works well against viruses surrounded by lipids--like COVID--the researchers believed that it would be a good fit for disinfecting the coronavirus.

To test their hypothesis, they put COVID samples in test tubes and then mixed in different compounds, including .2% benzalkonium chloride solution and three commercially available disinfectants containing quaternary ammonium compounds, as well as soil loads and hard water.

Working fast to simulate real-world conditions--because hand sanitizer has to disinfect quickly to be effective--they neutralized the disinfecting compounds, extracted the virus from the tubes, and placed the virus particles on living cells. The virus failed to invade and kill the cells, indicating that it had been deactivated by the compounds.

"A couple of others have looked at using these compounds against COVID," said Berges, "but we're the first to actually look at it in a practical timeframe, using four different options, with the realistic circumstance of having dirt on your hands before you use it."

The team believes their findings "may actually provide a change in government directions about hand sanitizer," Berges said.

Ogilvie hopes that reintroducing alcohol-free sanitizers into the market can relieve the shortages--and reduce the chances of people encountering some potentially "sketchy" alcohol sanitizers that have cropped up in response to the demand.

"Hand sanitizer can play an especially important role in controlling COVID," he concluded. "This is information that could affect millions of people."

The study is published online in the Journal of Hospital Infection.

Source:
Journal reference:

Ogilvie, B.H., et al. (2020) Alcohol-free hand sanitizer and other quaternary ammonium disinfectants quickly and effectively inactivate SARS-CoV-2. Journal of Hospital Infection. doi.org/10.1016/j.jhin.2020.11.023.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study finds nirmatrelvir-ritonavir reduces severe COVID-19 and long COVID risks in high-risk patients